Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Operating Income 2009–2025
Lexicon Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Lexicon Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2026 was -996000, a 96.12% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2026 was -35.1 M, a 83.59% decrease year-over-year.
- Lexicon Pharmaceuticals, Inc. annual operating income for 2025 was -48.9 M, a 75.19% decrease from 2024.
- Lexicon Pharmaceuticals, Inc. annual operating income for 2024 was -197.1 M, a 14.77% increase from 2023.
- Lexicon Pharmaceuticals, Inc. annual operating income for 2023 was -171.8 M, a 70.45% increase from 2022.
- Lexicon Pharmaceuticals, Inc. annual operating income for 2022 was -100.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexicon Pharmaceuticals, Inc. Operating Income — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexicon Pharmaceuticals, Inc.'s operating income?
Lexicon Pharmaceuticals, Inc. (LXRX) reported operating income of -$49M for fiscal 2025.
Where can I see LXRX's operating income history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.